-
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety Tolerability Pharmacokinetics of AHB-137 with Single Ascending Doses and Multiple Doses in Healthy Volunteers and Initial Efficacy in Chronic Hepatitis B Patients
This phase I study is designed to evaluate the safety, tolerability, and pharmacokinetics of AHB-137 in healthy participants and initial efficacy in CHB patients. A ... -
GUT KIDNEY AXIS IN ENTERIC HYPEROXALURIA - A clinical prospective study of the effects of the microbiome on urinary oxalate in participants with enteric hyperoxaluria fed a moderate oxalate diet
40 subjects with a confirmed diagnosis of IBD or >6 months post-RYGB with a diagnosed USD event or kidney stone on imaging within the past ... -
Development and Piloting of a Family-Centered mHealth-Enhanced Intervention to Promote Caregiving Mastery in Detection Prevention and Management of Delirium Superimposed on Dementia
Delirium superimposed on dementia (DSD) is an acute and serious condition that is common in persons living with dementia (PLWD). Involvement of family caregivers can ... -
Examining the Impact of Family Connectors
The purpose of this study is to examine the association between involvement in Family Connectors, a manualized peer-to-peer support and education program for family members ... -
CP-CGMH: Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring with Mobile Health: Improving Outcomes for Older Adults with Mild Cognitive Impairment
The purpose of this study is to examine the acceptability of continuous glucose monitoring (CGM) and identify the key domains of a future care partner-assisted ... -
Site for The HEALthy Brain and Child Development Study (HBCD)
Site for This multi-site consortium research study, entitled the HEALthy Brain and Child Development (HBCD) study, will prospectively examine human brain, cognitive, behavioral, social, and ... -
Safety and Immune Response Study of An Intranasal COVID-19 Booster Vaccine
The NYU Langone Vaccine Center Long Island site is enrolling adult volunteers, aged 18-64, for a clinical trial evaluating a new investigational NIH-DMID intranasal COVID-19 ...